JEOZIF PHARMA
0892.375.452 · rovalta.com · 25/09/2026
ACTIVE
JEOZIF PHARMA
Financial year 2024 · Closed on 31/03/2024
Net result21,3 k €+4,0 %over 1 year
Gross margin30,1 k €+4,3 %over 1 year
Equity177,5 k €+13,6 %over 1 year
Overview
Identity
Source · BCE/KBOJEOZIF PHARMA is a Private company with limited liability incorporated in 2007. Its main activity is: Management consultancy activities. Its registered office is in Schaerbeek.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0892.375.452
- Incorporation
- 28/09/2007
- Legal form
- Private company with limited liability
- Registered office
- Avenue Jan Stobbaerts 10
1030 Schaerbeek · BruxellesSee on map - Contributed capital
- 6 200,00 €
- Latest accounts
- 31/03/2024
Activities (NACE)
Signals
ProfitableSolid equityPositive cashflowPositive EBITDA
Financials
Source · NBB, 15 filingsTrend over 15 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 30,1 k € | +4.3% | 28,9 k € | -21.9% | 37 k € | +56.9% | 23,6 k € | -1.7% | 24 k € |
| EBITDA | 29,7 k € | +4.2% | 28,5 k € | -22.1% | 36,6 k € | +57.7% | 23,2 k € | -1.6% | 23,6 k € |
| Operating result | 29,7 k € | +4.2% | 28,5 k € | -22.1% | 36,6 k € | +57.7% | 23,2 k € | -1.6% | 23,6 k € |
| Net result | 21,3 k € | +4.0% | 20,4 k € | -6.9% | 22 k € | +68.5% | 13 k € | +6.5% | 12,2 k € |
| Balance sheet | |||||||||
| Equity | 177,5 k € | +13.6% | 156,2 k € | +13.4% | 137,7 k € | +19.0% | 115,8 k € | +12.7% | 102,7 k € |
| Total assets | 538,9 k € | +7.3% | 502,2 k € | -0.5% | 504,7 k € | +2.3% | 493,4 k € | -0.5% | 496 k € |
| Cash | 2,9 k € | -43.7% | 5,1 k € | -18.0% | 6,2 k € | +21.7% | 5,1 k € | +27.9% | 4 k € |
| Debts | 361,5 k € | +4.5% | 346 k € | -5.7% | 367 k € | -2.8% | 377,6 k € | -4.0% | 393,3 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
See the valuationBoard of directors
Source · NBB, accounts to 31/03/20241 active · 1 ended
Active mandates
Jeosif Butros
ActiveEnded mandates
Jeosif Butros
EndedOther companies at this address
Avenue Jan Stobbaerts 10 1030 Schaerbeek| Company | CBE no. |
|---|---|
D-PHARMA● Active | 0455.755.092 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/04/2023 | 01/04/2022 | 01/04/2021 | 01/04/2020 | 01/04/2019 | 01/04/2017 |
| Closing of the financial year | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 | 31/03/2020 | 31/03/2018 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 28/11/2024 | 30/11/2023 | 30/12/2022 | 29/11/2021 | 13/11/2020 | 30/11/2018 |
| General meeting | 27/09/2024 | 01/09/2023 | 02/09/2022 | 24/09/2021 | 25/09/2020 | 21/09/2018 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/03/2024 | 27/09/2024 | 28/11/2024 | French | |
| Micro model | 31/03/2023 | 01/09/2023 | 30/11/2023 | French | |
| Micro model | 31/03/2022 | 02/09/2022 | 30/12/2022 | French | |
| Micro model | 31/03/2021 | 24/09/2021 | 29/11/2021 | French | |
| Micro model | 31/03/2020 | 25/09/2020 | 13/11/2020 | French | |
| Micro model | 31/03/2018 | 21/09/2018 | 30/11/2018 | French | |
| Micro model | 31/03/2017 | 22/09/2017 | 30/11/2017 | French | |
| Abridged model | 31/03/2016 | 30/08/2016 | 28/11/2016 | French | |
| Abridged model | 31/03/2015 | 21/08/2015 | 30/11/2015 | French | |
| Abridged model | 31/03/2014 | 29/09/2014 | 28/11/2014 | French | |
| Abridged model | 31/03/2013 | 27/09/2013 | 29/11/2013 | French | |
| Abridged model | 31/03/2012 | 22/10/2012 | 31/10/2012 | French | |
| Abridged model | 31/03/2011 | 10/11/2011 | 14/11/2011 | French | |
| Abridged model | 31/03/2010 | 04/01/2011 | 14/02/2011 | French | |
| Abridged model | 31/03/2009 | 16/10/2009 | 20/11/2009 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/03/20241 active · 1 ended
Active mandates
Jeosif Butros
ActiveEnded mandates
Jeosif Butros
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other08/10/2007RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 202421,3 k €↑
- 2023Annual accounts 202320,4 k €↓
- 2022Annual accounts 202222 k €↑
- 2021Annual accounts 202113 k €↑
- 2020Annual accounts 202012,2 k €↓
- 2018Annual accounts 201818,2 k €↑
- 2017Annual accounts 201715,3 k €↓
- 2016Annual accounts 201619,1 k €↑
- 2015Annual accounts 201518,1 k €↑
- 2014Annual accounts 20145,6 k €↓
- 2013Annual accounts 20138,1 k €↑
- 2012Annual accounts 2012-1,1 k €↓
- 2011Annual accounts 20115,3 k €↑
- 2010Annual accounts 20102,2 k €↑
- 2009Annual accounts 2009-7,3 k €
- 28/09/2007IncorporationPrivate company with limited liability